One pill a day could slash stroke risk in ghana

NCT ID NCT05963568

Recruiting now Disease control Sponsor: Northern California Institute of Research and Education Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times

Summary

This study tests whether a single daily polypill (combining blood pressure, cholesterol, and anti-clotting drugs) can help recent stroke survivors in Ghana avoid future strokes or heart attacks. About 500 participants will take the polypill or receive usual care for 24 months. The goal is to see if the polypill improves control of key risk factors and is practical for use in low-resource settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke Medication Adherence stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MEDICATION ADHERENCE STROKE

Contacts and locations

Locations

Aga Khan Hospital
NOT_YET_RECRUITING

Dar es Salaam, Tanzania
Kwame Nkrumah Institute of Science & Technology
ACTIVE_NOT_RECRUITING

Kumasi, Ghana
University Teaching Hospital of Parakou
RECRUITING

Parakou, Benin
University of Ilorin Teaching Hospital
RECRUITING

Ilorin, Nigeria

More trials for these conditions

Other studies related to the condition(s) this trial covers.